Adoption of the 2013 American College of Cardiology/ American Heart Association Cholesterol Management Guideline in cardiology practices nationwide

JAMA Cardiology

Volumn 2, Issue 4, 2017, Pages 361-369

  Pokharel, Yashashwi ^a,b   Tang, Fengming ^a   Jones, Philip G ^a   Nambi, Vijay ^c,d,e   Bittner, Vera A ^f   Hira, Ravi S ^g   Nasir, Khurram ^h   Chan, Paul S ^a,b   Maddox, Thomas M ⁱ   Oetgen, William J ^j   Heidenreich, Paul A ^k   Borden, William B ^l   Spertus, John A ^a,b   Petersen, Laura A ^c,d   Ballantyne, Christie M ^d,e   Virani, Salim S ^c,d,e  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^f University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h Baptist Health South Florida   (United States)

ⁱ UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^j AMERICAN COLLEGE OF CARDIOLOGY   (United States)

^k STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; BIOLOGICAL MARKER; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; BRAIN ISCHEMIA; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HUMAN; INFORMED CONSENT; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; TRANSIENT ISCHEMIC ATTACK; TREND STUDY; UNSTABLE ANGINA PECTORIS; BLOOD; CARDIOLOGY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DISEASE MANAGEMENT; INCIDENCE; MEDICAL SOCIETY; MULTICENTER STUDY; PROCEDURES; PROTOCOL COMPLIANCE; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; UNITED STATES;

AGED; AMERICAN HEART ASSOCIATION; BIOMARKERS; CARDIOLOGY; CARDIOVASCULAR DISEASES; CHOLESTEROL; DISEASE MANAGEMENT; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; UNITED STATES;

EID: 85019662542     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2016.5922     Document Type: Article

References (28)

1. Stone NJ, Robinson JG, Lichtenstein AH, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25, PtB):2889-2934.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19): 2486-2497.
3. Arnold SV, Spertus JA, Tang F, et al. Statin use in outpatients with obstructive coronary artery disease. Circulation. 2011;124(22):2405-2410.
4. Ioannidis JP. More than a billion people taking statins? potential implications of the new cardiovascular guidelines. JAMA. 2014;311(5):463-464.
5. Pencina MJ, Navar-Boggan AM, D’Agostino RB Sr, et al. Application of new cholesterol guidelines to a population-based sample. N Engl J Med. 2014; 370(15):1422-1431.
6. Schoen MW, Salas J, Scherrer JF, Buckhold FR. Cholesterol treatment and changes in guidelines in an academic medical practice. Am J Med. 2015;128 (4):403-409.
7. Ridker PM, Cook NR. Statins: new American guidelines for prevention of cardiovascular disease. Lancet. 2013;382(9907):1762-1765.
8. Yeboah J, Sillau S, Delaney JC, et al. Implications of the new American College of Cardiology/ American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2015;169(3):387-395.e3.
9. Chan PS, Oetgen WJ, Buchanan D, et al. Cardiac performance measure compliance in outpatients: the American College of Cardiology and National Cardiovascular Data Registry’s PINNACLE (Practice Innovation and Clinical Excellence) program. J Am Coll Cardiol. 2010;56(1):8-14.
10. Virani SS, Woodard LD, Ramsey DJ, et al. Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol. 2015;115(1):21-26.
11. Virani SS, Woodard LD, Akeroyd JM, Ramsey DJ, Ballantyne CM, Petersen LA. Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clin Cardiol. 2014;37(11):653-659.
12. Rosenson RS, Kent ST, Brown TM, et al. Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease. J Am Coll Cardiol. 2015;65(3):270-277.
13. Penfold RB, Zhang F. Use of interrupted time series analysis in evaluating health care quality improvements. Acad Pediatr. 2013;13(6)(suppl): S38-S44.
14. Tran JN, Kao TC, Caglar T, et al. Impact of the 2013 cholesterol guideline on patterns of lipid-lowering treatment in patients with atherosclerotic cardiovascular disease or diabetes after 1 year. J Manag Care Spec Pharm. 2016;22(8): 901-908.
15. Rodriguez F, Lin S, Maron DJ, Knowles JW, Virani SS, Heidenreich PA. Use of high-intensity statins for patients with atherosclerotic cardiovascular disease in the Veterans Affairs Health System: Practice impact of the new cholesterol guidelines. Am Heart J. 2016;182:97-102.
16. Gaskin FS, Iyengar R, Eatherly M, et al. Impact of new ACC/AHA cholesterol treatment guidelines on statin utilization patterns in the United States. J Am Coll Cardiol. 2016;67(13)(suppl):1962. Abstract 1191-388.
17. Committee on Quality of Health Care in America, Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
18. Miedema MD, Lopez FL, Blaha MJ, et al. Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US cohort: the Atherosclerosis Risk in Communities Study Cohort. JAMA Intern Med. 2015;175(1):138-140.
19. DeFilippis AP, Young R, Carrubba CJ, et al. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med. 2015;162(4): 266-275.
20. Nasir K, Bittencourt MS, Blaha MJ, et al. Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2015;66(15):1657-1668.
21. Pursnani A, Massaro JM, D’Agostino RB Sr, O’Donnell CJ, Hoffmann U. Guideline-based statin eligibility, coronary artery calcification, and cardiovascular events. JAMA. 2015;314(2):134-141.
22. Naci H, Brugts JJ, Fleurence R, Tsoi B, Toor H, Ades AE. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials. Eur J Prev Cardiol. 2013;20 (4):641-657.
23. Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1(1): CD004816.
24. Amin NP, Martin SS, Blaha MJ, Nasir K, Blumenthal RS, Michos ED. Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines. J Am Coll Cardiol. 2014;63(25, pt A): 2789-2794.
25. Ray KK, Kastelein JJ, Boekholdt SM, et al. The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. Eur Heart J. 2014;35(15):960-968.
26. Virani SS, Pokharel Y, Steinberg L, et al. Provider understanding of the 2013 ACC/AHA cholesterol guideline. J Clin Lipidol. 2016;10(3):497-504.e4. doi:10.1016/j.jacl.2015.11.002
27. Pokharel Y, Steinberg L, Chan W, et al. Case-based educational intervention to assess change in providers’ knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association cholesterol management guideline. Atherosclerosis. 2016; 246:115-120.
28. Banach M, Rizzo M, Toth PP, et al. Statin intolerance: an attempt at a unified definition: position paper from an international lipid expert panel. Arch Med Sci. 2015;11(1):1-23.